摘要 |
The present invention provides a pharmaceutical composition containing a calcium channel blocker of the following formula or a pharmacologically acceptable salt thereof and a pharmacologically acceptable alkaline material which is added to an extent such that an aqueous solution or dispersion solution of said pharmaceutical composition containing a calcium channel blocker has a pH of at least 8: [wherein R<SUP>1 </SUP>represents an optionally substituted C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl group, an amino group or a cyano group; R<SUP>2 </SUP>represents an optionally substituted C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl group, a substituted C<SUB>3</SUB>-C<SUB>4 </SUB>alkenyl group, or a substituted 4- to 6-membered cyclic amino group; R<SUP>3 </SUP>represents a substituted phenyl group; R<SUP>4 </SUP>represents an optionally substituted C<SUB>1</SUB>-C<SUB>4 </SUB>alkoxycarbonyl group, a 1,3,2-phosphorinan-2-yl group, or a 5,5-dimethyl-1,3,2-phosphorinan-2-yl group, R<SUP>5 </SUP>represents a C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl group].
|